General Mills heads into its June 24 earnings with short sellers in active rebuild mode, the options market pricing more defensive cover, and a Wall Street that has been cutting targets with rare unanimity.
The short-interest story is the clearest signal this week. Short interest climbed 6.2% over the past seven days to 8.5% of free float — a five-week high after a brief dip in late May. The move is part of a broader grind: shorts have added roughly 11% net over the past month, steadily moving from around 7.6% of free float in late April to the current level. With 45 million shares sold short against a float of roughly 534 million, this is a genuinely material short position for a large-cap consumer staples name. The ORTEX short score, at 59.5, sits in mild-bearish territory and has held that range without escalating further, suggesting the build is deliberate rather than panicked.
The lending market is not adding pressure. Availability remains ample at 234% of estimated short interest — meaning the pool of shares still available to borrow is more than twice the existing short position. Cost to borrow, at 0.48%, is low by any standard and eased about 6.5% over the past week despite the rise in positioned shorts. That combination — rising shorts, loose borrow — tells you this is informed directional positioning, not a squeeze-risk setup.
Options positioning is tilting more defensive than usual. The put/call ratio reached 0.84 on Tuesday, nearly two standard deviations above its 20-day mean of 0.75. Relative to the past year's range (low: 0.67, high: 1.18), the reading isn't extreme, but the direction of travel over the past two weeks is unmistakeable. The PCR has moved steadily higher since mid-May, tracking the drift lower in the share price. The stock is down 4.8% over the past month and closed at $33.07 on Tuesday.
The Street has delivered an unusually synchronised verdict. Every analyst action logged in the past six weeks has been a price target cut — from JP Morgan (to $31 from $36, maintaining Underweight), UBS (to $30 from $35, Sell), Bank of America (to $36 from $42, Neutral), Wells Fargo (to $30 from $33, Underweight), Barclays (to $36 from $41), and Piper Sandler (to $41 from $45, retaining its lone Overweight). No firm upgraded; none raised a target. The consensus sits at Hold, with the mean target at $37.83 — above where the stock trades, but the gap is compressing fast given the direction of revisions. The bull case from the more optimistic houses rests on Q4 sequential improvement from supply-chain gains and inventory restocking. Bears — and they are in the majority — point to continued category softness in cereal, structural pet-segment destocking, COGS inflation, and tariff drag bleeding into FY27. Factor scores reinforce that picture: EPS momentum over both 30 and 90 days ranks in the bottom quartile of the universe (22nd and 24th percentile respectively), and forward earnings growth ranks just 18th. The dividend score, at the 90th percentile, remains the one obvious bright spot for income-focused holders.
Insider activity over the 90-day window has been one-directional. The HR director sold 20,000 shares across two transactions in mid-May, a division president sold just under 8,000 shares around the same time, and a non-executive director added a symbolic 190 shares at $33.65 on May 29. Net 90-day insider activity totals roughly 28,000 shares sold at values between $34 and $34.50 — levels above Tuesday's close, suggesting those sellers caught most of the recent move. There is no offsetting buying cluster from senior management.
The prior earnings print on March 18 saw the stock fall 3.2% on the day and a further 6.6% over the following five sessions. Peers confirmed the sector tone this week: CAG dropped 1.9% on Tuesday and is off 2.2% for the week; KHC lost 1.3% on the day. CPB was a notable exception, gaining 4.3% on the week. The June 24 print is the next forcing event — and what matters then is whether management can demonstrate that the Q4 sequential improvement the bulls are counting on has actually materialised in volumes, not just in guidance language.
See the live data behind this article on ORTEX.
Open GIS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
